1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
(
- Contribution to journal › Article
-
Mark
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)
(
- Contribution to journal › Article
- 2022
-
Mark
Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1
(
- Contribution to journal › Article
- 2019
-
Mark
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
(
- Contribution to journal › Article
-
Mark
Differentiation of diabetes by pathophysiology, natural history, and prognosis
(
- Contribution to journal › Scientific review